Literature DB >> 35066183

Regional heterogeneity in determinants of atrial matrix remodeling and association with atrial fibrillation vulnerability postmyocardial infarction.

Mitchel R Stacy1, Ben A Lin1, Stephanie L Thorn1, David C Lobb2, Mark W Maxfield1, Craig Novack2, Kia N Zellars2, Lisa Freeburg2, Joseph G Akar1, Albert J Sinusas3, Francis G Spinale4.   

Abstract

BACKGROUND: Left ventricular (LV) remodeling following a myocardial infarction (MI) is associated with new-onset atrial fibrillation (AF). LV remodeling post-MI is characterized by regional changes in matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), causing extracellular matrix (ECM) remodeling.
OBJECTIVE: The purpose of this study was to test the hypothesis that a shift in regional atrial MMP activity, MMP/TIMP expression, and ECM remodeling occurs post-MI, which cause increased vulnerability to AF.
METHODS: MI was induced in pigs (weight 25 kg; coronary ligation; n = 9). At approximately 14 days post-MI, an atrial electrical stimulation protocol was performed, after which an MMP radiotracer was infused, MMP/TIMP mRNA profiling performed, and ECM collagen assessed by histochemistry. An additional 7 non-MI pigs served as controls.
RESULTS: AF could be induced in 89% (8/9) of the post-MI pigs but none of the controls. MMP activity (MMP radiotracer uptake) increased by approximately 2-fold in most atrial regions post-MI, whereas fibrillar collagen content was unchanged or actually reduced in right atrial regions and increased in left atrial regions. MMP/TIMP profiles revealed a heterogeneous pattern from the left atrial appendage to right atrial regions.
CONCLUSION: AF vulnerability early post-MI was associated with a heterogeneous pattern of atrial ECM remodeling, detectable by noninvasive molecular imaging. Detection of early atrial MMP activation post-MI may help define the myocardial substrate underlying AF.
Copyright © 2022 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Extracellular matrix; Heart failure; Inflammasome; Inflammation; Myocardial remodeling

Mesh:

Substances:

Year:  2022        PMID: 35066183      PMCID: PMC9064890          DOI: 10.1016/j.hrthm.2022.01.022

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.779


  27 in total

Review 1.  Inflammasomes and Proteostasis Novel Molecular Mechanisms Associated With Atrial Fibrillation.

Authors:  Na Li; Bianca J J M Brundel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

2.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.

Authors:  D Li; S Fareh; T K Leung; S Nattel
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

3.  Association of MMP-9 gene polymorphisms with atrial fibrillation in hypertensive heart disease patients.

Authors:  Xiaobo Gai; Xiaopeng Lan; Zhurong Luo; Feifei Wang; Yonggang Liang; Hueimin Zhang; Wenli Zhang; Jianping Hou; Mingfang Huang
Journal:  Clin Chim Acta       Date:  2009-08-07       Impact factor: 3.786

Review 4.  Assessment of Left Atrial Fibrosis by Late Gadolinium Enhancement Magnetic Resonance Imaging: Methodology and Clinical Implications.

Authors:  Johannes Siebermair; Eugene G Kholmovski; Nassir Marrouche
Journal:  JACC Clin Electrophysiol       Date:  2017-08-21

5.  Impact of matrix metalloproteinase-2 levels on long-term outcome following pharmacological or electrical cardioversion in patients with atrial fibrillation.

Authors:  Kimihiko Kato; Tetsuo Fujimaki; Tetsuro Yoshida; Mitsutoshi Oguri; Kazuhiro Yajima; Takeshi Hibino; Toyoaki Murohara
Journal:  Europace       Date:  2009-01-15       Impact factor: 5.214

6.  Left Atrial LGE and Arrhythmia Recurrence Following Pulmonary Vein Isolation for Paroxysmal and Persistent AF.

Authors:  Irfan M Khurram; Mohammadali Habibi; Esra Gucuk Ipek; Jonathan Chrispin; Eunice Yang; Kotaro Fukumoto; Jane Dewire; David D Spragg; Joseph E Marine; Ronald D Berger; Hiroshi Ashikaga; Jack Rickard; Yiyi Zhang; Vadim Zipunnikov; Stefan L Zimmerman; Hugh Calkins; Saman Nazarian
Journal:  JACC Cardiovasc Imaging       Date:  2016-01-06

7.  Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation.

Authors:  Yukiko Nakano; Shumpei Niida; Keigo Dote; Sou Takenaka; Hidekazu Hirao; Fumiharu Miura; Mari Ishida; Tetsuji Shingu; Taijiro Sueda; Masao Yoshizumi; Kazuaki Chayama
Journal:  J Am Coll Cardiol       Date:  2004-03-03       Impact factor: 24.094

8.  Cardiomyocyte Inflammasome Signaling in Cardiomyopathies and Atrial Fibrillation: Mechanisms and Potential Therapeutic Implications.

Authors:  Gong Chen; Mihail G Chelu; Dobromir Dobrev; Na Li
Journal:  Front Physiol       Date:  2018-08-13       Impact factor: 4.566

9.  Characterization of a porcine model of atrial arrhythmogenicity in the context of ischaemic heart failure.

Authors:  Sebastian Clauss; Dominik Schüttler; Christina Bleyer; Julia Vlcek; Mehdi Shakarami; Philipp Tomsits; Sarah Schneider; Florian Maderspacher; Kavi Chataut; Anna Trebo; Christine Wang; Jan Kleeberger; Ruibing Xia; Elisabeth Baloch; Bianca Hildebrand; Steffen Massberg; Reza Wakili; Stefan Kääb
Journal:  PLoS One       Date:  2020-05-04       Impact factor: 3.240

10.  CTRP9 Ameliorates Atrial Inflammation, Fibrosis, and Vulnerability to Atrial Fibrillation in Post-Myocardial Infarction Rats.

Authors:  Mingxin Liu; Wei Li; Huibo Wang; Lin Yin; Bingjie Ye; Yanhong Tang; Congxin Huang
Journal:  J Am Heart Assoc       Date:  2019-10-18       Impact factor: 5.501

View more
  1 in total

1.  Hub Genes Identification, Small Molecule Compounds Prediction for Atrial Fibrillation and Diagnostic Model Construction Based on XGBoost Algorithm.

Authors:  Lingzhi Yang; Yunwei Chen; Wei Huang
Journal:  Front Cardiovasc Med       Date:  2022-07-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.